Polycitra-LC and Trastuzumab Injection (Intravenous)
Determining the interaction of Polycitra-LC and Trastuzumab Injection (Intravenous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: n.a.
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Polycitra-LC-Trastuzumab Intravenous
- Polycitra-LC-Trastuzumab-anns
- Polycitra-LC-Trastuzumab-dkst
- Polycitra-LC-Trastuzumab-dkst Intravenous
- Polycitra-LC-Trasylol
- Polycitra-LC-Travasol
- Trastuzumab Injection (Intravenous)-Polyethylene Glycol 3350 NF PEGYLAX
- Trastuzumab Injection (Intravenous)-Polyethylene Glycol
- Trastuzumab Injection (Intravenous)-Polyethylene glycol 3350
- Trastuzumab Injection (Intravenous)-Polyethylene glycol 3350 and electrolytes
- Trastuzumab Injection (Intravenous)-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Trastuzumab Injection (Intravenous)-Polyethylene glycol 3350, sodium and potassium salts